Voluntarily recall of a further nine batches of daptomycin for injection


FDA report “Cubist Pharmaceuticals, Inc.is voluntarily recalling nine lots of CUBICIN (daptomycin for injection) to the user level following complaints of foreign particulate matter in reconstituted vials. Refer to the Press Release for a list of affected products.”

Click here for the full alert.

Other intravenous and vascular access resources that may be of interest (External links – IVTEAM has no responsibility for content).

Main page


Comments are closed.